Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemia

被引:15
作者
Wakita, Satoshi [1 ]
Marumo, Atsushi [1 ]
Morita, Kaoru [2 ]
Kako, Shinichi [3 ]
Toya, Takashi [4 ]
Najima, Yuho [4 ]
Doki, Noriko [4 ]
Kanda, Junya [5 ]
Kuroda, Junya [6 ]
Mori, Shinichiro [7 ]
Satake, Atsushi [8 ]
Usuki, Kensuke [9 ]
Ueki, Toshimitsu [10 ]
Uoshima, Nobuhiko [11 ]
Kobayashi, Yutaka [11 ]
Kawata, Eri [12 ]
Nakayama, Kazutaka [13 ]
Nagao, Yuhei [14 ]
Shono, Katsuhiro [14 ]
Shibusawa, Motoharu [15 ]
Tadokoro, Jiro [15 ]
Hagihara, Masao [16 ]
Uchiyama, Hitoji [17 ]
Uchida, Naoyuki [18 ]
Kubota, Yasushi [19 ]
Kimura, Shinya [19 ]
Nagoshi, Hisao [20 ]
Ichinohe, Tatsuo [20 ]
Kurosawa, Saiko [21 ]
Motomura, Sayuri [22 ]
Hashimoto, Akiko [23 ]
Muto, Hideharu [24 ]
Sato, Eriko [25 ]
Ogata, Masao [26 ]
Mitsuhashi, Kenjiro [27 ]
Ando, Jun [28 ]
Tashiro, Haruko [29 ]
Sakaguchi, Masahiro [1 ]
Yui, Shunsuke [1 ]
Arai, Kunihito [1 ]
Kitano, Tomoaki [1 ]
Miyata, Miho [1 ]
Arai, Haruka [1 ]
Kanda, Masayuki [1 ]
Itabashi, Kako [1 ]
Fukuda, Takahiro [21 ]
Kanda, Yoshinobu [2 ,3 ]
Yamaguchi, Hiroki [1 ]
机构
[1] Nippon Med Sch, Dept Hematol, 1-1-5 Sendagi,Bunkyo Ku, Tokyo 1138603, Japan
[2] Jichi Med Univ, Dept Med, Div Hematol, Shimotsuke, Tochigi, Japan
[3] Jichi Med Univ, Div Hematol, Saitama Med Ctr, Saitama, Japan
[4] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Hematol Div, Tokyo, Japan
[5] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto, Japan
[6] Kyoto Prefectural Univ Med, Div Hematol & Oncol, Kyoto, Japan
[7] St Lukes Int Hosp, Hematol Dept, Tokyo, Japan
[8] Kansai Med Univ, Dept Internal Med 1, Osaka, Japan
[9] NTT Med Ctr Tokyo, Dept Hematol, Tokyo, Japan
[10] Nagano Red Cross Hosp, Dept Hematol, Nagano, Japan
[11] Kyoto Daini Hosp, Dept Hematol, Japanese Red Cross, Kyoto, Japan
[12] Panasonic Hlth Insurance Org Matsushita Mem Hosp, Dept Hematol, Osaka, Japan
[13] Yokohama Minami Kyousai Hosp, Dept Hematol, Yokohama, Japan
[14] Chiba Aoba Municipal Hosp, Dept Hematol, Chiba, Japan
[15] IMS Grp Shinmatsudo Cent Gen Hosp, Dept Hematol, Chiba, Japan
[16] Eiju Gen Hosp, Dept Hematol, Tokyo, Japan
[17] Japanese Red Cross Kyoto Daiichi Hosp, Dept Hematol, Kyoto, Japan
[18] Toranomon Gen Hosp, Dept Hematol, Federat Natl Publ Serv Personnel Mutual Aid Assoc, Tokyo, Japan
[19] Saga Univ, Fac Med, Dept Internal Med, Div Hematol Resp Med & Oncol, Saga, Japan
[20] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Hematol & Oncol, Hiroshima, Japan
[21] Natl Canc Ctr, Dept Hematopoiet Stem Cell Transplantat, Tokyo, Japan
[22] Tokyo Metropolitan Hlth & Med Treatment Corp, Tama Hokubu Med Ctr, Dept Hematol, Tokyo, Japan
[23] Kobe City Nishi Kobe Med Ctr, Dept Immunol & Hematol, Kobe, Japan
[24] Tokyo Metropolitan Otsuka Hosp, Div Hematol, Tokyo, Japan
[25] Juntendo Univ, Dept Hematol, Nerima Hosp, Tokyo, Japan
[26] Oita Univ Hosp, Dept Hematol, Yufu, Oita, Japan
[27] Saitama Red Cross Hosp, Dept Hematol, Saitama, Japan
[28] Juntendo Univ, Dept Internal Med, Div Hematol, Sch Med, Tokyo, Japan
[29] Teikyo Univ, Dept Hematol Oncol, Sch Med, Tokyo, Japan
关键词
acute myeloid leukemia; DNMT3A; NPM1; prognostic factor; triple mutation; ACUTE MYELOGENOUS LEUKEMIA; NPM1; MUTATIONS; GENE-MUTATIONS; NUCLEOPHOSMIN; IMPACT; ADULTS; AML; DIAGNOSIS; FLT3-ITD;
D O I
10.1111/cas.15720
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nucleophosmin1 (NPM1) mutations are the most frequently detected gene mutations in acute myeloid leukemia (AML) and are considered a favorable prognostic factor. We retrospectively analyzed the prognosis of 605 Japanese patients with de novo AML, including 174 patients with NPM1-mutated AML. Although patients with NPM1-mutated AML showed a high remission rate, this was not a favorable prognostic factor for overall survival (OS); this is contrary to generally accepted guidelines. Comprehensive gene mutation analysis showed that mutations in codon R882 of DNA methyltransferase 3A (DNMT3A(R882) mutations) were a strong predicative factor indicating poor prognosis in all AML (p < 0.0001) and NPM1-mutated AML cases (p = 0.0020). Furthermore, multivariate analysis of all AML cases showed that DNMT3A(R882) mutations and the co-occurrence of internal tandem duplication in FMS-like tyrosine kinase 3 (FLT3-ITD), NPM1 mutations, and DNMT3A(R882) mutations (triple mutations) were independent factors predicting a poor prognosis related to OS, with NPM1 mutations being an independent factor for a favorable prognosis (hazard ratios: DNMT3A(R882) mutations, 1.946; triple mutations, 1.992, NPM1 mutations, 0.548). Considering the effects of DNMT3A(R882) mutations and triple mutations on prognosis and according to the classification of NPM1-mutated AML into three risk groups based on DNMT3A(R882)/FLT3-ITD genotypes, we achieved the improved stratification of prognosis (p < 0.0001). We showed that DNMT3A(R882) mutations are an independent factor for poor prognosis; moreover, when confounding factors that include DNMT3A(R882) mutations were excluded, NPM1 mutations were a favorable prognostic factor. This revealed that ethnological prognostic discrepancies in NPM1 mutations might be corrected through prognostic stratification based on the DNMT3A status.
引用
收藏
页码:1297 / 1308
页数:12
相关论文
共 31 条
[1]   Prognostic Impact of Concurrent DNMT3A, FLT3 and NPM1 Gene Mutations in Acute Myeloid Leukemia Patients [J].
Abd Elrhman, Heba Allah E. ;
El-Meligui, Yomna M. ;
Elalawi, Saffaa M. .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (12) :E960-E969
[2]   DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation [J].
Ahn, Jae-Sook ;
Kim, Hyeoung-Joon ;
Kim, Yeo-Kyeoung ;
Lee, Seun-Shin ;
Jung, Sung-Hoon ;
Yang, Deok-Hwan ;
Lee, Je-Jung ;
Kim, Nan Young ;
Choi, Seung Hyun ;
Jung, Chul Won ;
Jang, Jun-Ho ;
Kim, Hee Je ;
Moon, Joon Ho ;
Sohn, Sang Kyun ;
Won, Jong-Ho ;
Kim, Sung-Hyun ;
Kim, Dennis Dong Hwan .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (01) :61-70
[3]   Co-occurrence of DNMT3A, NPM1, FLT3 mutations identifies a subset of acute myeloid leukemia with adverse prognosis [J].
Bezerra, Matheus F. ;
Lima, Aleide S. ;
Pique-Borras, Maria-Riera ;
Silveira, Douglas R. ;
Coelho-Silva, Juan L. ;
Pereira-Martins, Diego A. ;
Weinhauser, Isabel ;
Franca-Neto, Pedro L. ;
Quek, Lynn ;
Corby, Anna ;
Oliveira, Mayara M. ;
Lima, Marinus M. ;
de Assis, Reijane A. ;
Campos, Paula de Melo ;
Duarte, Bruno K. ;
Bendit, Israel ;
Rocha, Vanderson ;
Rego, Eduardo M. ;
Traina, Fabiola ;
Saad, Sara T. ;
Beltrao, Eduardo I. ;
Bezerra, Marcos A. ;
Lucena-Araujo, Antonio R. .
BLOOD, 2020, 135 (11) :870-875
[4]   Nucleophosmin mutation in Southeast Asian acute myeloid leukemia:: eight novel variants, FLT3 coexistence and prognostic impact of NPM1/FLT3 mutations [J].
Boonthimat, Chetsada ;
Thongnoppakhun, Wanna ;
Auewarakul, Chirayu U. .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (10) :1565-1569
[5]   Nucleophosmin mutations in De novo acute myeloid leukemia:: The age-dependent incidences and the stability during disease [J].
Chou, WC ;
Tang, JL ;
Lin, LI ;
Yao, M ;
Tsay, W ;
Chen, CY ;
Wu, SJ ;
Huang, CF ;
Chiou, RJ ;
Tseng, MH ;
Lin, DT ;
Lin, KH ;
Chen, YC ;
Tien, HF .
CANCER RESEARCH, 2006, 66 (06) :3310-3316
[6]   Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN [J].
Doehner, Hartmut ;
Wei, Andrew H. ;
Appelbaum, Frederick R. ;
Craddock, Charles ;
DiNardo, Courtney D. ;
Dombret, Herve ;
Ebert, Benjamin L. ;
Fenaux, Pierre ;
Godley, Lucy A. ;
Hasserjian, Robert P. ;
Larson, Richard A. ;
Levine, Ross L. ;
Miyazaki, Yasushi ;
Niederwieser, Dietger ;
Ossenkoppele, Gert ;
Roellig, Christoph ;
Sierra, Jorge ;
Stein, Eytan M. ;
Tallman, Martin S. ;
Tien, Hwei-Fang ;
Wang, Jianxiang ;
Wierzbowska, Agnieszka ;
Lowenberg, Bob .
BLOOD, 2022, 140 (12) :1345-1377
[7]   Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel [J].
Doehner, Hartmut ;
Estey, Elihu ;
Grimwade, David ;
Amadori, Sergio ;
Appelbaum, Frederick R. ;
Buechner, Thomas ;
Dombret, Herve ;
Ebert, Benjamin L. ;
Fenaux, Pierre ;
Larson, Richard A. ;
Levine, Ross L. ;
Lo-Coco, Francesco ;
Naoe, Tomoki ;
Niederwieser, Dietger ;
Ossenkoppele, Gert J. ;
Sanz, Miguel ;
Sierra, Jorge ;
Tallman, Martin S. ;
Tien, Hwei-Fang ;
Wei, Andrew H. ;
Lowenberg, Bob ;
Bloomfield, Clara D. .
BLOOD, 2017, 129 (04) :424-447
[8]   Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics:: interaction with other gene mutations [J].
Döhner, K ;
Schlenk, RF ;
Habdank, M ;
Scholl, C ;
Rücker, FG ;
Corbacioglu, A ;
Bullinger, L ;
Fröhling, S ;
Döhner, H .
BLOOD, 2005, 106 (12) :3740-3746
[9]   Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. [J].
Falini, B ;
Mecucci, C ;
Tiacci, E ;
Alcalay, M ;
Rosati, R ;
Pasqualucci, L ;
La Starza, R ;
Diverio, D ;
Colombo, E ;
Santucci, A ;
Bigerna, B ;
Pacini, R ;
Pucciarini, A ;
Liso, A ;
Vignetti, M ;
Fazi, P ;
Meani, N ;
Pettirossi, V ;
Saglio, G ;
Mandelli, F ;
Lo-Coco, F ;
Pelicci, P ;
Martelli, MF .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :254-266
[10]   Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG) [J].
Gaidzik, Verena I. ;
Schlenk, Richard F. ;
Paschka, Peter ;
Stoelzle, Anja ;
Spaeth, Daniela ;
Kuendgen, Andrea ;
von Lilienfeld-Toal, Marie ;
Brugger, Wolfram ;
Derigs, Hans Guenter ;
Kremers, Stephan ;
Greil, Richard ;
Raghavachar, Aruna ;
Ringhoffer, Mark ;
Salih, Helmut R. ;
Wattad, Mohammed ;
Kirchen, Heinz G. ;
Runde, Volker ;
Heil, Gerhard ;
Petzer, Andreas L. ;
Girschikofsky, Michael ;
Heuser, Michael ;
Kayser, Sabine ;
Goehring, Gudrun ;
Teleanu, Maria-Veronica ;
Schlegelberger, Brigitte ;
Ganser, Arnold ;
Krauter, Juergen ;
Bullinger, Lars ;
Doehner, Hartmut ;
Doehner, Konstanze .
BLOOD, 2013, 121 (23) :4769-4777